Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACNOS: N-acetylcysteine for Smoking Cessation
NCT02124525Phase 3Unknown
- Sponsor
- Universidade Estadual de Londrina
- Start
- Feb 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in Tobacco Use Disorder (TUD), sponsored by Universidade Estadual de Londrina. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02124525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124525.